Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,998 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, not recruiting

A Study to Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma

NCT05950165

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Tri-Service General Hospital - Neihu Branch - Hematology Taipei, Taiwan
  • Taipei Medical University - Shuang Ho Hospital - Oncology New Taipei City, Taipei Special Municipality, Taiwan
  • National Taiwan University Hospital Yunlin Branch Huwei, Taiwan
  • Chi-Mei Medical Center Tainan, Taiwan
View Trial Details
Active, not recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma

NCT05169515

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • UCSF/Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Chicago Chicago, Illinois, United States
View all 25 locations
View Trial Details
Active, not recruiting

Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma

NCT06216158

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Universitätsklinikum Krems an der Donau Krems, Austria
  • Ordensklinikum Linz Elisabethinen Linz, Austria
  • Landeskrankenhaus Salzburg, Universitätsklinik für Innere Medizin III Salzburg, Austria
  • Klinik Ottakring Wien Vienna, Austria
View all 69 locations
View Trial Details
Active, not recruiting

Agriculture Health Study

NCT00352924

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Genital Diseases, +25 more
Locations
  • Research Triangle Institute Research Triangle Park, North Carolina, United States
View Trial Details
Active, not recruiting

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma

NCT05259839

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of Arkansas for Medical Sciences /ID# 243096 Little Rock, Arkansas, United States
  • Sylvester Comprehensive Cancer Center /ID# 243673 Miami, Florida, United States
  • Moffitt Cancer Center /ID# 243437 Tampa, Florida, United States
  • University of Maryland, Baltimore /ID# 243679 Baltimore, Maryland, United States
View all 49 locations
View Trial Details
Active, not recruiting

A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors

NCT05428176

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +14 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Childrens Hospital of Los Angeles Los Angeles, California, United States
  • Rady Children's Hospital San Diego San Diego, California, United States
  • University of Calif San Francisco San Francisco, California, United States
View Trial Details

Related conditions